New Delhi: Oncquest Laboratories Ltd. acclaimed as one of India’s prominent Super Specialized Laboratory Network is stepping up its operations through a joint partnership with Makashir Diagnostics. This new joint laboratory is in the heart of Lajpat Nagar, New Delhi. By establishing this laboratory, Oncquest has expanded its lab count to two in the South Delhi region with an aim to serve for its rising demand. Having made a name for itself in the field of cancer diagnostics across South-East Asia, Oncquest Laboratories yearn to diligently cater to the needs of its clients and stand up to the reputation it has garnered in the past 20 years. The vision behind this partnership between Oncquest and Makashir was to make it convenient for patients to access a wide range of diagnostic tests and procedures nearer to them.

Makashir-Oncquest Laboratories can be easily located at 1/4, Vikram Vihar, Lajpat Nagar 4, New Delhi 110024. Sprawling across an area of 1000 sq ft, the well built diagnostic lab aspires to live up to its stature with all modern and certified equipments.  The advanced state-of-the-art diagnostic lab of Oncquest, combined with Makashir Diagnostics’ commitment to quality will provide services that render accurate, precise and rapid results. The services would not only include simple routine tests, but also would cover an array of specialized, super specialized categories of tests and highly advanced genome testing.  Furthermore, Oncquest being aware of the significance of a second opinion in the field of medical science, has always endeavoured to bring to the fore cutting-edge diagnostic tools, a diversified range of meticulous tests, highly proficient pathologists and technicians.

The inaugural ceremony of the new laboratory was graced by honourable Dr. Bobby Grewal, president of the Delhi Medical Association and Mrs. Meenu Mehta, President of the Vikram Vihar Residents’ Welfare Association. Dr. Grewal’s presence amplified the fervour of the inaugural ceremony. With enthusiasm in his voice, Dr. Ravinder Deep Singh Sethi, Chief Operating Officer, Oncquest Laboratories Ltd. addressed the event and said “Since the past 20 years, Oncquest has treaded a very long and successful journey in the medical industry. We comprise of a team of highly skilful doctors whose repute is well known in the medical fraternity across the globe and that is why is relied on for second opinions and final testing. Alongside offering a diversified scope of tests, Oncquest also provides economic and customizable health check packages. With each lab that we envision of and set up, the only aim at the backdrop is to ensure availability and accessibility of the latest diagnostic tests, modern equipment coupled with well trained individuals. Expansion is just a means to achieve this vision and Oncquest is committed at accomplishing this vision across India. Oncquest acknowledges this partnership with Makashir Diagnostics as having the potential of leaving a huge impact in the whole of Delhi NCR.”

Speaking at the occasion, Dr. Rajesh Makashir, the owner of Makashir Diagnostics was elated about having partnered with Oncquest and said that “What triggered Makashir Diagnostics’ partnership with Oncquest Laboratories is the rising demand of reliable diagnostics centres equipped with modern technologies and diagnostic tools. Commended for it precision, Makashir Diagnostics has always strived to provide comprehensive tests and swifter results. Makashir Diagnostics, founded in 1995 had a humble beginning as a small lab in Lajpat Nagar, New Delhi. Founded by Dr Rajesh Makashir and his wife, Dr. Swati Makashir, now spearheaded by his daughter, Dr. Monalisa Makashir and son-in-law, Mr. Parag Laturkar, the lab has grown into a reputed, well-known lab in South Delhi. With Makashir Diagnostics’ uncompromising focus on integrity, quality and service and Oncquest’s state-of-the-art technology and a large test menu, the partnership with Oncquest is a step at fortifying Makashir’s name as one of the forerunners in the medical fraternity for diagnostics services.”